Xianming Mo
- Aging top 1%
- Virology top 5%
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 8
- Oncology top 5%
- Cancer Cells and Metastasis 28
- Peptidase Inhibition and Analysis 6
- Cancer-related Molecular Pathways 5
-
- RNA Interference and Gene Delivery 9
- RNA modifications and cancer 7
- DNA Repair Mechanisms 6
-
- Cancer Research and Treatments 7
- Co-authors
- Achim LeutzElisabeth Kowenz‐LeutzWentong MengWenhui HuYonggang ZhangHong XuKamel KhaliliFang Li
- Journals
- Journal of Cancer Research and Clinical Oncology (5 papers)Scientific Reports (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xianming Mo
113 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Aging 193
- Business and International Management 117
- Virology 212
- Cancer Research 562
- Oncology 937
Countries citing papers authored by Xianming Mo
This map shows the geographic impact of Xianming Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianming Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianming Mo more than expected).
Fields of papers citing papers by Xianming Mo
This network shows the impact of papers produced by Xianming Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianming Mo. The network helps show where Xianming Mo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianming Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2021 | 28 | |
| 6 | 2021 | 38 | |
| 7 | 2021 | 30 | |
| 8 | 2017 | 33 | |
| 9 | 2016 | 113 | |
| 10 | 2016 | 30 | |
| 11 | 2015 | 53 | |
| 12 | RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infectionbreakdown → | 2014 | 411 |
| 13 | Immunohistochemical HER2 expression not associated with clinicopathological characteristics of stage I-III gastric cancer patients. | 2014 | 8 |
| 14 | 2014 | 22 | |
| 15 | 2013 | 2 | |
| 16 | 2012 | 1 | |
| 17 | 2012 | 28 | |
| 18 | 2012 | 90 | |
| 19 | 2008 | 35 | |
| 20 | 2005 | 56 |
About Xianming Mo
Xianming Mo is a scholar working on Oncology, Cancer Research, Aging, Molecular Biology and Cell Biology, having authored 116 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (28 papers), RNA Interference and Gene Delivery (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer Research and Treatments (7 papers), RNA modifications and cancer (7 papers), DNA Repair Mechanisms (6 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Aging (193 citations), Business and International Management (117 citations), Virology (212 citations), Cancer Research (562 citations) and Oncology (937 citations). Xianming Mo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Achim Leutz, Elisabeth Kowenz‐Leutz, Wentong Meng, Wenhui Hu, Yonggang Zhang, Hong Xu, Kamel Khalili, Fang Li, Moshe J. Sadofsky and Bailin Tu. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Scientific Reports, Oncotarget, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.